Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine Glioma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Albert Cornelius, MD
Helen DeVos Children's Hospital
Principal Investigator - Giselle Sholler, MD
Beat Childhood Cancer at Atrium Health
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Helen Devos Children'S Hospital
Grand Rapids, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2013
- Primary completion
- 31 Oct 2015
- Completion
- 31 Oct 2015
- Last update posted
- 6 Aug 2024
- Registered enrollment
- 9
- Registry id
- NCT01774253
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.